OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bifunctional degraders of cyclin dependent kinase 9 (CDK9): Probing the relationship between linker length, properties, and selective protein degradation
Robert J. Tokarski, Chia M. Sharpe, Andrew C. Huntsman, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115342-115342
Closed Access | Times Cited: 12
Robert J. Tokarski, Chia M. Sharpe, Andrew C. Huntsman, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115342-115342
Closed Access | Times Cited: 12
Showing 12 citing articles:
Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications
Yuming Zhang, Lianhai Shan, Wentao Tang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5185-5215
Closed Access | Times Cited: 10
Yuming Zhang, Lianhai Shan, Wentao Tang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5185-5215
Closed Access | Times Cited: 10
CDK9 targeting PROTAC L055 inhibits ERα-positive breast cancer
Wen‐Ming Chen, Yue Wu, Chuanyu Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116972-116972
Open Access | Times Cited: 2
Wen‐Ming Chen, Yue Wu, Chuanyu Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116972-116972
Open Access | Times Cited: 2
Targeted protein degradation: advances in drug discovery and clinical practice
Guangcai Zhong, Xiaoyu Chang, Weilin Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Guangcai Zhong, Xiaoyu Chang, Weilin Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Protein kinases: The key contributors in pathogenesis and treatment of nonalcoholic fatty liver disease-derived hepatocellular carcinoma
Rong Liu, Mingping Qian, Ying‐Yu Cui
Metabolism (2023) Vol. 147, pp. 155665-155665
Closed Access | Times Cited: 7
Rong Liu, Mingping Qian, Ying‐Yu Cui
Metabolism (2023) Vol. 147, pp. 155665-155665
Closed Access | Times Cited: 7
PROTACs in Ovarian Cancer: Current Advancements and Future Perspectives
Makenzie Vorderbruggen, Carlos A. Velázquez‐Martínez, Amarnath Natarajan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5067-5067
Open Access | Times Cited: 1
Makenzie Vorderbruggen, Carlos A. Velázquez‐Martínez, Amarnath Natarajan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5067-5067
Open Access | Times Cited: 1
Targeting Cyclin-Dependent Kinases: From Pocket Specificity to Drug Selectivity
Yaoguang Huang, Wenwu Liu, Changhao Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116547-116547
Closed Access | Times Cited: 1
Yaoguang Huang, Wenwu Liu, Changhao Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116547-116547
Closed Access | Times Cited: 1
Examination of the Impact of Triazole Position within Linkers on Solubility and Lipophilicity of a CDK9 Degrader Series
Oluwatosin R. Ayinde, Chia Sharpe, Emily Stahl, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 7, pp. 936-942
Closed Access | Times Cited: 3
Oluwatosin R. Ayinde, Chia Sharpe, Emily Stahl, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 7, pp. 936-942
Closed Access | Times Cited: 3
Review of the impact of fragment-based drug design on PROTAC degrader discovery
Peiqi Chen, Qiang Li, Xiaoguang Lei
TrAC Trends in Analytical Chemistry (2024) Vol. 171, pp. 117539-117539
Closed Access
Peiqi Chen, Qiang Li, Xiaoguang Lei
TrAC Trends in Analytical Chemistry (2024) Vol. 171, pp. 117539-117539
Closed Access
Discovery of Novel PROTAC SIRT6 Degraders with Potent Efficacy against Hepatocellular Carcinoma
Jinbo Huang, Jiajie Su, Haiyu Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 19, pp. 17319-17349
Closed Access
Jinbo Huang, Jiajie Su, Haiyu Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 19, pp. 17319-17349
Closed Access
PROTACs of cyclin-dependent kinases
Denisa Veselá, Eva Řezníčková, Václav Mik, et al.
Annual reports in medicinal chemistry (2024)
Closed Access
Denisa Veselá, Eva Řezníčková, Václav Mik, et al.
Annual reports in medicinal chemistry (2024)
Closed Access
The roles of ubiquitination in AML
Zhifeng Wei, Long Su, Sujun Gao
Annals of Hematology (2023) Vol. 103, Iss. 9, pp. 3413-3428
Closed Access | Times Cited: 1
Zhifeng Wei, Long Su, Sujun Gao
Annals of Hematology (2023) Vol. 103, Iss. 9, pp. 3413-3428
Closed Access | Times Cited: 1
